We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EC Recommends Risk-Based Approach to Process Validation
EC Recommends Risk-Based Approach to Process Validation
The European Commission has updated its GMP guideline on process validation to reflect the EU’s current risk-based approach to managing quality systems over the entire lifecycle of a drug.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor